Cargando…
Neil3 induced neurogenesis protects against prion disease during the clinical phase
Base excision repair (BER) is the major pathway for repair of oxidative DNA damage. Mice with genetic knockout of the BER enzyme Neil3 display compromised neurogenesis in the sub-ventricular zone of the lateral ventricle and sub-granular layer of the dentate gyrus of the hippocampus. To elucidate th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122945/ https://www.ncbi.nlm.nih.gov/pubmed/27886261 http://dx.doi.org/10.1038/srep37844 |
_version_ | 1782469667225337856 |
---|---|
author | Jalland, Clara M. O. Scheffler, Katja Benestad, Sylvie L. Moldal, Torfinn Ersdal, Cecilie Gunnes, Gjermund Suganthan, Rajikala Bjørås, Magnar Tranulis, Michael A. |
author_facet | Jalland, Clara M. O. Scheffler, Katja Benestad, Sylvie L. Moldal, Torfinn Ersdal, Cecilie Gunnes, Gjermund Suganthan, Rajikala Bjørås, Magnar Tranulis, Michael A. |
author_sort | Jalland, Clara M. O. |
collection | PubMed |
description | Base excision repair (BER) is the major pathway for repair of oxidative DNA damage. Mice with genetic knockout of the BER enzyme Neil3 display compromised neurogenesis in the sub-ventricular zone of the lateral ventricle and sub-granular layer of the dentate gyrus of the hippocampus. To elucidate the impact of oxidative DNA damage-induced neurogenesis on prion disease we applied the experimental prion disease model on Neil3-deficient mice. The incubation period for the disease was similar in both wild type and Neil3(−/−) mice and the overall neuropathology appeared unaffected by Neil3 function. However, disease in the Neil3(−/−) mice was of shorter clinical duration. We observed a mildly reduced astrogliosis in the hippocampus and striatum in the Neil3-deficient mice. Brain expression levels of neuronal progenitor markers, nestin (Nestin), sex determining region Box 2 (Sox2), Class III beta-tubulin (Tuj1) decreased towards end-stage prion disease whereas doublecortin (Dcx) levels were less affected. Neuronal nuclei (NeuN), a marker for mature neurons declined during prion disease and more pronounced in the Neil3(−/−) group. Microglial activation was prominent and appeared unaffected by loss of Neil3. Our data suggest that neurogenesis induced by Neil3 repair of oxidative DNA damage protects against prion disease during the clinical phase. |
format | Online Article Text |
id | pubmed-5122945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51229452016-12-07 Neil3 induced neurogenesis protects against prion disease during the clinical phase Jalland, Clara M. O. Scheffler, Katja Benestad, Sylvie L. Moldal, Torfinn Ersdal, Cecilie Gunnes, Gjermund Suganthan, Rajikala Bjørås, Magnar Tranulis, Michael A. Sci Rep Article Base excision repair (BER) is the major pathway for repair of oxidative DNA damage. Mice with genetic knockout of the BER enzyme Neil3 display compromised neurogenesis in the sub-ventricular zone of the lateral ventricle and sub-granular layer of the dentate gyrus of the hippocampus. To elucidate the impact of oxidative DNA damage-induced neurogenesis on prion disease we applied the experimental prion disease model on Neil3-deficient mice. The incubation period for the disease was similar in both wild type and Neil3(−/−) mice and the overall neuropathology appeared unaffected by Neil3 function. However, disease in the Neil3(−/−) mice was of shorter clinical duration. We observed a mildly reduced astrogliosis in the hippocampus and striatum in the Neil3-deficient mice. Brain expression levels of neuronal progenitor markers, nestin (Nestin), sex determining region Box 2 (Sox2), Class III beta-tubulin (Tuj1) decreased towards end-stage prion disease whereas doublecortin (Dcx) levels were less affected. Neuronal nuclei (NeuN), a marker for mature neurons declined during prion disease and more pronounced in the Neil3(−/−) group. Microglial activation was prominent and appeared unaffected by loss of Neil3. Our data suggest that neurogenesis induced by Neil3 repair of oxidative DNA damage protects against prion disease during the clinical phase. Nature Publishing Group 2016-11-25 /pmc/articles/PMC5122945/ /pubmed/27886261 http://dx.doi.org/10.1038/srep37844 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Jalland, Clara M. O. Scheffler, Katja Benestad, Sylvie L. Moldal, Torfinn Ersdal, Cecilie Gunnes, Gjermund Suganthan, Rajikala Bjørås, Magnar Tranulis, Michael A. Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title | Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title_full | Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title_fullStr | Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title_full_unstemmed | Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title_short | Neil3 induced neurogenesis protects against prion disease during the clinical phase |
title_sort | neil3 induced neurogenesis protects against prion disease during the clinical phase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122945/ https://www.ncbi.nlm.nih.gov/pubmed/27886261 http://dx.doi.org/10.1038/srep37844 |
work_keys_str_mv | AT jallandclaramo neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT schefflerkatja neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT benestadsylviel neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT moldaltorfinn neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT ersdalcecilie neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT gunnesgjermund neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT suganthanrajikala neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT bjørasmagnar neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase AT tranulismichaela neil3inducedneurogenesisprotectsagainstpriondiseaseduringtheclinicalphase |